4baseCare, a precision oncology company focused on building population-relevant clinico-genomic intelligence, has raised an additional Rs 38 crore in an extended Series B funding round. The round was led by growX ventures, with participation from existing investors. This top-up brings the company's total Series B raise to Rs 128 crore, according to a company statement.
Earlier this year, 4baseCare had announced a Rs 90 crore Series B round, co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing backer Yali Capital. The company is now expanding its hospital-linked genomics laboratory network across India, Southeast Asia, Latin America, and Central Asia. The goal is to improve access to advanced genomic testing and precision cancer care worldwide.
